Jamf Holding $163 million follow-on offering
The common stock is listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
MediaAlpha $144.2 million secondary offering
The Class A common stock is listed on the New York Stock Exchange
AC Immune exclusive option and license agreement with Takeda Pharmaceuticals
We advised AC Immune on the transaction
Biodesix $55 million follow-on offering
The common stock is listed on the Nasdaq Global Market
MediaAlpha $59.6 million secondary offering
The stock is listed on the New York Stock Exchange
Prime Medicine $161 million stock and pre-funded warrants offering
The common stock is listed on the Nasdaq Global Market
Estée Lauder $650 million senior notes offering
The investment-grade notes are due 2034
Truist sale of Sterling Capital Management to Guardian Capital
We are advising Truist on the transaction
TKO Group Holdings $666 million secondary offering
The stock is listed on the New York Stock Exchange
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction